![Brendan O'Grady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brendan O'Grady
Directeur Général chez
AUSPEX PHARMACEUTICALS INC
Fortune : 201 514 $ au 31/05/2026
Profil
Brendan P.
O'Grady is currently Chief Executive Officer at Auspex Pharmaceuticals, Inc. and Director at the Association for Accessible Medicines.
Former roles include CEO-Global Formulations Business at Glenmark Pharmaceuticals Ltd. from 2022 to 2024, Director at Pharmaceutical Research & Manufacturers of America, Director at Assertio Holdings, Inc. in 2025, EVP-North America Commercial Division at Teva Pharmaceutical Industries Ltd. from 2017 to 2021, and Chief Commercial & Growth Officer at American Well Corp.
from 2021 to 2022.
Education includes an MBA from Baker University conferred in 2004 and an undergraduate degree from State University of New York College at Geneseo conferred in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2026 | 8 597 ( 0,13% ) | 201 514 $ | 31/05/2026 |
Postes actifs de Brendan O'Grady
| Sociétés | Poste | Début |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Directeur Général | - |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services Operate as a pharmaceutical association | Directeur/Membre du Conseil | - |
Anciens postes connus de Brendan O'Grady
| Sociétés | Poste | Fin |
|---|---|---|
| ASSERTIO HOLDINGS | Directeur Général | 28/10/2025 |
| GLENMARK PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/02/2024 |
| AMERICAN WELL CORPORATION | Directeur/Membre du Conseil | 19/07/2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 15/08/2021 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
Formation de Brendan O'Grady
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
American Well Corp.
 American Well Corp. Packaged SoftwareTechnology Services Develops software platform for healthcare industry | Technology Services |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Baker University
 Baker University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York College at Geneseo
 State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services Operate as a pharmaceutical association | Commercial Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Assertio Holdings, Inc.
 Assertio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
